Prognostic factors for patients with borderline resectable pancreatic cancer treated with neoadjuvant chemoradiotherapy

Prognostic factors for patients with borderline resectable pancreatic cancer treated with neoadjuvant chemoradiotherapy

Aim: The aim of this study was to determine the prognostic significance of preoperative modified Glasgow Prognostic Score (mGPS), Neutrophil-to-lymphocyte ratio (NLR) and Platelet-to-lymphocyte ratio (PLR) in patients with borderline resectable pancreatic cancer treated with neoadjuvant chemoradioth...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2016-08, Vol.16 (4), p.S92-S92
Hauptverfasser: Kubo, Hirokazu, Mori, Ryutaro, Matsuyama, Ryusei, Yamada, Junki, Miyake, Kentaro, Hiratani, Seigo, Sawada, Yu, Ota, Yohei, Kumamoto, Takafumi, Takeda, Kazuhisa, Endo, Itaru
Format: Artikel
Sprache:eng
Schlagworte:
Endocrinology & Metabolism
Gastroenterology and Hepatology
Lymphocytes
Neutrophils
Pancreatic cancer
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aim: The aim of this study was to determine the prognostic significance of preoperative modified Glasgow Prognostic Score (mGPS), Neutrophil-to-lymphocyte ratio (NLR) and Platelet-to-lymphocyte ratio (PLR) in patients with borderline resectable pancreatic cancer treated with neoadjuvant chemoradiotherapy.
ISSN:1424-3903
1424-3911
DOI:10.1016/j.pan.2016.06.329